Baron Funds, an investment management company, released its “Baron Health Care Fund” fourth quarter 2024 investor letter. The Fund performed roughly in line with the Benchmark, during a challenging ...

Eli Lilly 's blockbuster weight loss drugs, and questions about its valuation. Then, Ricky continues his conversation with ...

While the issue has fallen from the headlines after several moves to cap the cost, some patients with diabetes still often ...

Lilly is testing bimagrumab alone and in combination with Novo's Wegovy -- a mid-stage trial begun before the acquisition -- ...

Some doctors say drugs that improve muscle mass could benefit older or infirm people at greater risk of falls and fractures.

Lebanon Plan Commission on Monday night unanimously approved a design plan for Eli Lilly and Co.’s $4.5 billion center for advanced manufacturing and drug development at the LEAP Research and ...

A real-world study in Spain finds faster improvements with induction therapy but highlights long-term drug survival ...

Altimmune's existence depends almost entirely on the outcome of the Phase 2 trial for pemvidutide in MASH. Learn why ALT ...

About Zappy Health: Customers say they were drawn to the online provider by its low prices, its lack of subscription fees and ...

A telehealth company partnered with a pharmacy that lacked a required license, raising doubts about the safety and efficacy ...